Evolutionary Genomics, Inc. Deferred Tax Assets, Valuation Allowance
Evolutionary Genomics, Inc. had Deferred Tax Assets, Valuation Allowance of $3.19 million as of 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2023-03-09
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $3.19M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $2.84M.
- 2020-12-31: Deferred Tax Assets, Valuation Allowance $2.06M.
- 2019-12-31: Deferred Tax Assets, Valuation Allowance $2.37M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2022-12-31 | $3.19M 10-K · filed 2023-03-09 | |
| 2021-12-31 | $2.84M 10-K · filed 2023-03-09 | |
| 2020-12-31 | $2.06M 10-K · filed 2022-03-22 | |
| 2019-12-31 | $2.37M 10-K · filed 2021-03-31 | |
| 2018-12-31 | $2.18M 10-K · filed 2020-03-30 | |
| 2017-12-31 | $1.90M 10-K · filed 2019-04-01 | |
| 2016-12-31 | $2.18M 10-K · filed 2018-03-05 | |
| 2015-12-31 | $1.56M 10-K · filed 2017-02-10 | |
| 2014-12-31 | $1.47M 10-K · filed 2016-02-19 | -$65.56K 10-K · filed 2015-03-05 |
| 2013-12-31 | -$112.08K 10-K · filed 2015-03-05 | |
| 2012-12-31 | -$108.51K 10-K · filed 2014-04-16 | |
| 2011-12-31 | -$105.36K 10-K · filed 2013-04-15 |